75 related articles for article (PubMed ID: 7546854)
21. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
22. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
23. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
24. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
25. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
26. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
27. [Amplification of oncogene c-erb-B1 and cellular DNA content in squamous cell carcinoma of the head and neck].
Rodrigo Tapia JP; Martínez Sánchez JA; Sánchez Lazo P; Ramos S; Sampedro Nuño A; Suárez Nieto C
Acta Otorrinolaringol Esp; 1996; 47(2):97-103. PubMed ID: 8695214
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma.
Sang-Hyuk Lee SH; Lee NH; Jin SM; Rho YS; Jo SJ
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):64-70. PubMed ID: 21493295
[TBL] [Abstract][Full Text] [Related]
30. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
Jungehülsing M; Volling P
HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
[TBL] [Abstract][Full Text] [Related]
31. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
32. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
[TBL] [Abstract][Full Text] [Related]
33. [Surgical therapy of malignant and benign diseases of the hypopharynx. I].
Stell PM; Bowdler DA
Laryngorhinootologie; 1999 Sep; 78(9):OP81-8. PubMed ID: 10535073
[No Abstract] [Full Text] [Related]
34. MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma.
Masferrer E; Ferrándiz-Pulido C; Lloveras B; Masferrer-Niubò M; Espinet B; Salido M; Rodríguez-Rivera M; Alemany L; Placer J; Gelabert A; Servitje O; García-Patos V; Pujol RM; Toll A
J Urol; 2012 Nov; 188(5):1965-71. PubMed ID: 22999547
[TBL] [Abstract][Full Text] [Related]
35. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
36. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
38. Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells.
Chattopadhyay P; Banerjee M; Sarkar C; Mathur M; Mohapatra AK; Sinha S
Oncogene; 1995 Dec; 11(12):2711-4. PubMed ID: 8545130
[TBL] [Abstract][Full Text] [Related]
39. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
